Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy
ICD-10 E09.35 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy.
E09.35 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of proliferative diabetic retinopathy. This condition arises when certain medications or chemical exposures lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. Proliferative diabetic retinopathy is a severe complication of diabetes, marked by the growth of new blood vessels in the retina, which can lead to vision loss if not managed appropriately. Patients may present with symptoms such as blurred vision, floaters, or sudden vision changes. Management of this condition often requires a multidisciplinary approach, including endocrinology for diabetes management and ophthalmology for retinal care. Regular monitoring of HbA1c levels is crucial, as it reflects long-term glucose control and helps guide treatment decisions. Insulin therapy may be necessary for glycemic control, especially in cases where oral hypoglycemics are ineffective due to the drug-induced nature of the diabetes.
Detailed medication history, HbA1c levels, and treatment plans.
Patients presenting with new-onset diabetes after starting a specific medication.
Ensure clear documentation of the relationship between the drug and diabetes onset.
Visual acuity tests, retinal examination findings, and treatment plans for retinopathy.
Patients with diabetes presenting for routine eye exams or with vision changes.
Document the severity of retinopathy and any interventions performed.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any changes in medication.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Used when treating proliferative diabetic retinopathy.
Document the extent of retinopathy and treatment rationale.
Ophthalmologists must document visual acuity and retinal findings.
Several classes of medications can induce diabetes, including corticosteroids, certain antipsychotics, and some chemotherapy agents. It is important to review the patient's medication history to identify potential causes.
Proliferative diabetic retinopathy is diagnosed through a comprehensive eye exam, which may include retinal photography and fluorescein angiography to assess the extent of neovascularization.
